Return to study ST001652 main page

Download data matrix(Atypical Molecular Basis for Drug Resistance to Mitochondrial AQ: A Function Inhibitors in Plasmodium falciparum Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODE19_A6_AT2Genotype:Drug Resistant | Treatment:AtovaquonePeak intensity
Reversed phase NEGATIVE ION MODE28_A6_AT3Genotype:Drug Resistant | Treatment:AtovaquonePeak intensity
Reversed phase NEGATIVE ION MODE9_A6_AT1Genotype:Drug Resistant | Treatment:AtovaquonePeak intensity
Reversed phase NEGATIVE ION MODE21_A6_CT2Genotype:Drug Resistant | Treatment:ControlPeak intensity
Reversed phase NEGATIVE ION MODE31_A6_CT3Genotype:Drug Resistant | Treatment:ControlPeak intensity
Reversed phase NEGATIVE ION MODE7_A6_CT1Genotype:Drug Resistant | Treatment:ControlPeak intensity
Reversed phase NEGATIVE ION MODE17_D6_DT2Genotype:Drug Resistant | Treatment:DSM-1Peak intensity
Reversed phase NEGATIVE ION MODE20_A6_DT2Genotype:Drug Resistant | Treatment:DSM-1Peak intensity
Reversed phase NEGATIVE ION MODE26_A6_DT3Genotype:Drug Resistant | Treatment:DSM-1Peak intensity
Reversed phase NEGATIVE ION MODE8_A6_DT1Genotype:Drug Resistant | Treatment:DSM-1Peak intensity
Reversed phase NEGATIVE ION MODE12_D6_AT1Genotype:Wild-type | Treatment:AtovaquonePeak intensity
Reversed phase NEGATIVE ION MODE16_D6_AT2Genotype:Wild-type | Treatment:AtovaquonePeak intensity
Reversed phase NEGATIVE ION MODE25_D6_AT3Genotype:Wild-type | Treatment:AtovaquonePeak intensity
Reversed phase NEGATIVE ION MODE10_D6_CT1Genotype:Wild-type | Treatment:ControlPeak intensity
Reversed phase NEGATIVE ION MODE18_D6_CT2Genotype:Wild-type | Treatment:ControlPeak intensity
Reversed phase NEGATIVE ION MODE29_D6_CT3Genotype:Wild-type | Treatment:ControlPeak intensity
Reversed phase NEGATIVE ION MODE11_D6_DT1Genotype:Wild-type | Treatment:DSM-1Peak intensity
  logo